openPR Logo
Press release

Cardiovascular Devices Market Forecast Covering Growth Inclinations & Development Strategies until 2027: General Electric Company, Koninklijke Philips, Siemens AG, BD, B. Braun Melsungen, Edwards Lifesciences Corporation

08-01-2019 05:58 AM CET | Science & Education

Press release from: The Insight Partners

The Insight Partners

The Insight Partners

Cardiovascular diseases (CVDs) are likely to remain the largest cause of morbidity and mortality across the world. The CVDs are the disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease and other conditions. Some of the major lifestyle factors which leads to the cardiovascular disease and difficulties are use of tobacco, unhealthy diet, and physical inactivity increases the risk of heart attacks and strokes. Whereas, the other risk factors for the cardiovascular diseases are high blood pressure, diabetes, increased level of cholesterol levels. CVDs are among the top ten leading causes of death across the world, it affects more people as compared to any other disease. According to the World Health Organization, cardiovascular diseases are number one cause of the death across the world. As per WHO data published in 2017, states that, in 2016, approximately 17.9 million people died from CVDs, which was 31.0% of all the global deaths. Thus, owing to the factors the market is likely to grow during the forecast period.

The growth of the market is driven by the factors such as, significantly increasing prevalence of cardiovascular diseases and increasing elderly population. However, the market is likely to slower down its growth due to high cost of products and procedures in the region.

Get Sample Report at https://www.theinsightpartners.com/sample/TIPHE100000826?utm_source=OpenPR&utm_medium=SK

The rising population of the elderly people is the major cause of the heart diseases in the region. The heart diseases are mostly pone to the elderly people due to weak immunity and major other health problems. For instance, the number of Americans above the age of 65 and older is anticipated to grow more than double from US$ 46 million in 2016 to above US$ 98 million by 2060, and the 65-and-older age group’s share in the world’s population will grow around 24%from 15 percent. In addition, as per the report of UN, in 2012, the number of older persons (aged 60 years or over) is expected to more than double. The number is estimated to reach around 2 billion in 2050 from 841 million in 2013. The number of older persons in the world is anticipated to be US$ 1.4 billion in 2030 and US$ 2.1 billion in 2050, and will rise above US$ 3.1 billion in 2100. The elderly population are more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. The major reason for the disease are related to the structural and functional changes in the cardiovascular system associated with the aging.

Germany is expected to lead the market in the Europe region owing to increasing percentage of the incidences increases with the growing age and growing advanced technology. Moreover, rise in the prevalence of the cardiovascular diseases is majorly contributed by the elderly population helps to upsurge the market. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Europe region during the forecast period.

Check for Discount at https://www.theinsightpartners.com/discount/TIPRE00005823?utm_source=OpenPR&utm_medium=SK

CARDIOVASCULAR DEVICES - MARKET SEGMENTATION

By Device
• Electrocardiography (ECG)
• Pacemaker
• Stent
• Defibrillator
• Cardiac Catheter
• Guidewire
• Heart Valve
• Event Monitor
• Others

By Application
• Coronary Heart Disease
• Sudden Cardiac Arrest
• Stroke
• Cerebrovascular Heart Disease
• Others

By End User
• Hospitals
• Ambulatory Surgical Centres
• Cardiac Centers

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o France
o Germany
o UK
o Spain
o Italy
• Asia Pacific (APAC)
o China
o India
o Japan
o Australia
o South Korea
• Middle East & Africa (MEA)
o Saudi Arabia
o South Africa
o UAE
• South America (SAM)
o Brazil
o Argentina

Buy this Report now at https://www.theinsightpartners.com/buy/TIPHE100000826?utm_source=OpenPR&utm_medium=SK

Contact us –
Phone : +1-646-491-9876
Email Id : sales@theinsightpartners.com
Website: https://www.theinsightpartners.com

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiovascular Devices Market Forecast Covering Growth Inclinations & Development Strategies until 2027: General Electric Company, Koninklijke Philips, Siemens AG, BD, B. Braun Melsungen, Edwards Lifesciences Corporation here

News-ID: 1816032 • Views:

More Releases from The Insight Partners

Fiber Optic Preform Market Set for Robust Growth with 21.7% CAGR from 2025 to 2031, Driven by High-Bandwidth Demand and Global Telecom Expansion
Fiber Optic Preform Market Set for Robust Growth with 21.7% CAGR from 2025 to 20 …
New York, US - December 10, 2025 - The Insight Partners has released a comprehensive new study on the Fiber Optic Preform Market, forecasting exceptional growth at a CAGR of 21.7% between 2025 and 2031. The market, valued at US$ XX million in 2024, is expected to witness significant expansion by 2031 as high-speed connectivity becomes critical worldwide. Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00009584/?utm_source=OpenPR&utm_medium=10759 The report provides an in-depth examination of market dynamics, emerging
A Complete Study Guide to Agritech
A Complete Study Guide to Agritech
Agritech, or agriculture technology, refers to the application of technical breakthroughs in agriculture to improve productivity, efficiency, and profitability. This involves leveraging technology to accelerate planting, developing crops that thrive in a variety of settings, and harvesting. It can also refer to the utilization of robotics, big data, artificial intelligence, or any other means essential to address the issues that the agricultural business confronts. These technologies enable farmers to collect
Aminophylline Market Top Players, Growth Opportunities and Current Status by 2031
Aminophylline Market Top Players, Growth Opportunities and Current Status by 203 …
The Global Aminophylline Market 2031 that centers around Aminophylline Market examines the significant components with a top to bottom methodology and empowers the client to survey the drawn-out based interest additionally predicts explicit executions. This report gives subjective investigation, clarifying item scope and expounding Market experiences and standpoint. To Get Sample Copy of Report, Click Here - https://www.theinsightpartners.com/sample/TIPRE00040084/?utm_source=OpenPR&utm_medium=10129 (Our SAMPLE COPY of the report offers a quick advent to the Study report
Intermittent Catheters Market to Reach US$ 3.83 Billion by 2031, Expanding at 4.6% CAGR
Intermittent Catheters Market to Reach US$ 3.83 Billion by 2031, Expanding at 4. …
The Intermittent Catheters Market is undergoing steady growth driven by a rising prevalence of urinary disorders, expanding geriatric populations, and major advancements in catheter design. According to recent industry assessments, the intermittent catheters market is projected to reach US$ 3.83 billion by 2031, up from US$ 2.67 billion in 2023, progressing at a 4.6% CAGR during 2023-2031. This projected growth reflects expanding clinical adoption, increased awareness of urinary self-catheterization, and

All 5 Releases


More Releases for CVDs

Global Cardiovascular Diagnostic & Monitoring Devices Market to Reach Over USD 2 …
The global cardiovascular diagnostic & monitoring devices market, valued at USD 14.2 billion in 2021, is projected to nearly double to over USD 29.0 billion by the end of 2031, expanding at a robust CAGR of 7.5% over the forecast period (2022-2031). Fueled by the surging burden of chronic cardiovascular diseases (CVDs), demand for early diagnosis, and rapid technological advancements including AI‐enabled monitors and minimally invasive implants the market presents
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecu …
"The contrast-enhanced ultrasound market is projected to grow at a CAGR of 6.1% during the forecast period (2023-2028)." The global contrast-enhanced ultrasound market is projected to reach USD 2.1 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. Factors such as rising geriatric population and increasing use of contrast agents are responsible for the increasing growth of this market. Increasing research and
RAS-acting Agents Market to Reach US$ 13.4 Billion by 2031 Due to Increase in pr …
The global 𝗥𝗔𝗦-𝗮𝗰𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗻𝘁𝘀 market is estimated to attain a valuation of US$ 13.4 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.2% during the forecast period, 2023-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of
Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by R …
According to the latest report by IMARC Group, titled "Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.80 Billion by 2027, exhibiting at a CAGR of 10.09% during 2022-2027. A ventricular assist device (VAD), also called a mechanical circulatory
Rising Prevalence of CVDs Leads to Increasing Demand for Cardiac Biomarkers
In 2021, the cardiac biomarkers industry contributes $8,459.6 million, and it is projected to rise at a rate of 10.5%, to capture $20,718.8 million revenue in 2030. It is led by the rising prevalence of acute coronary syndrome, increasing point-of-care testing kit demand, and technological advancements in the industry. Moreover, the surging investments in biomarker research, increasing CVDs incidences, and rising geriatric population are projected to boost the industry growth.
Global rise in the incidence and prevalence rate of cardiovascular diseases (CVD …
Global Cardiovascular Information Systems (Cvis) Market is projected to grow at a considerable growth rate owing to increasing prevalence of CVDs across the globe. According to WHO, in 2018, CVDs accounts for 17.7 million mortality per year, which means 31% mortalities across the globe. The CVIS systems support in the assessment of chronic conditions such as CHD (coronary heart disease), stroke, and other heart related disease. CVIS systems allow assembling